Results 211 to 220 of about 35,844 (248)

Denosumab as a Potential Disease-Modifying Treatment in Indolent Systemic Mastocytosis-Related Osteoporosis. [PDF]

JCEM Case Rep
Abbas M, Luthra P.
europepmc   +1 more source

Treatment with denosumab reduces second hip fracture risk in elderly patients with osteoporotic femoral neck fractures. [PDF]

BMC Musculoskelet Disord
Wang Y, Pan K, Li X, Lv Q, Shao Y, Cao L.   +5 more
europepmc   +1 more source

Significant Response to Denosumab Yet with Severe Rebound Hypercalcemia in a 9-Year-Old Boy with Aneurysmal Bone Cyst: A Case Report. [PDF]

Children (Basel)
Allain L, Elbaz S, Sathyakumar S, Le Gallou W, Coleman C, Coltin H, Eugène D, Gupta A, Lava SAG, Renzi S.   +9 more
europepmc   +1 more source

A New Model for Bone Health Management in Postmenopausal Early Breast Cancer Patients Undergoing Adjuvant Endocrine Therapy-The Predict & Prevent Project. [PDF]

Healthcare (Basel)
Gori S, Fabi A, Berardi R, Villa P, Zaniboni A, Prochilo T, Bighin C, Del Conte A, Riccardi F, Airoldi M, Chirco A, Cinieri S, Orlandi A, Assanti M, Valerio M, Tessari R, Mantoan C, Verzè M, Puglisi F, Nicolis F.   +19 more
europepmc   +1 more source

Osteoporosis in men: epidemiology and treatment with denosumab

, 2014
Sidlauskas KM, Sutton EE, Biddle MA
openalex   +1 more source

Denosumab for Primary Osteoporosis and Its Impact on Sarcopenia in the Chinese Population: Insights from Clinical Evidence and RANKL Pathway Mendelian Randomization. [PDF]

Clin Interv Aging
Li S, Hu S, Zheng X, Ku X, Zou J, Wang L, Nie G, Liu Y, Tian C, Ran J, Yang X, Yan M, Yin Y, Liu Y, Wan J, Peng W.   +15 more
europepmc   +1 more source

A systematic review of combination treatment strategies for osteoporosis. [PDF]

JBMR Plus
Nayak S, Greenspan SL.
europepmc   +1 more source

LUMIADE 3: Therapeutic Equivalence of Denosumab Biosimilar FKS518 to Reference Product in Postmenopausal Osteoporosis. [PDF]

J Endocr Soc
Krecipro-Nizinska E, Pluskiewicz W, Supronik J, Szeles P, Petit-Frere C, Varone E, Ferrari S, Valter I.   +7 more
europepmc   +1 more source

Modulatory efficacy of bone metabolism and safety of denosumab versus zoledronic acid in the treatment of bone and joint osteoporosis in elderly men. [PDF]

Front Pharmacol
He J, Mao Y, Gong W, Zhu H, Xiang P, Wang S, Dai X.   +6 more
europepmc   +1 more source